You are here

Article info

Article menu

Download PDFPDF

Original research
Efficacy of 48 hours dose of phenytoin in prevention of early post-traumatic seizure

Authors

  • Toyin Ayofe Oyemolade Department of Surgery, Federal Medical Centre, Owo, NigeriaDepartment of Neurological Surgery, University College Hospital, UCH, Ibadan, Nigeria PubMed articlesGoogle scholar articles
  • Augustine A Adeolu 3Department of Neurological Surgery, University College Hospital, UCH, Ibadan, NigeriaDepartment of Surgery, College of Medicine, University of Ibadan, Ibadan, Nigeria PubMed articlesGoogle scholar articles
  • Oluwakemi A Badejo 3Department of Neurological Surgery, University College Hospital, UCH, Ibadan, NigeriaDepartment of Surgery, College of Medicine, University of Ibadan, Ibadan, Nigeria PubMed articlesGoogle scholar articles
  • James A Balogun 3Department of Neurological Surgery, University College Hospital, UCH, Ibadan, NigeriaDepartment of Surgery, College of Medicine, University of Ibadan, Ibadan, Nigeria PubMed articlesGoogle scholar articles
  • Matthew T Shokunbi 3Department of Neurological Surgery, University College Hospital, UCH, Ibadan, NigeriaDepartment of Surgery, College of Medicine, University of Ibadan, Ibadan, Nigeria PubMed articlesGoogle scholar articles
  • Adefolarin O Malomo 3Department of Neurological Surgery, University College Hospital, UCH, Ibadan, NigeriaDepartment of Surgery, College of Medicine, University of Ibadan, Ibadan, Nigeria PubMed articlesGoogle scholar articles
  • Amos O Adeleye 3Department of Neurological Surgery, University College Hospital, UCH, Ibadan, NigeriaDepartment of Surgery, College of Medicine, University of Ibadan, Ibadan, Nigeria PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Amos O Adeleye; femdoy{at}yahoo.com
View Full Text

Citation

Oyemolade TA, Adeolu AA, Badejo OA, et al
Efficacy of 48 hours dose of phenytoin in prevention of early post-traumatic seizure
BMJ Neurology Open 2023;5:e000377. doi: 10.1136/bmjno-2022-000377

Publication history

  • Received October 17, 2022
  • Accepted January 2, 2023
  • First published January 11, 2023.
Online issue publication 
January 11, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.